TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Tumor Infiltrating T Lymphocyte (TIL) Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Safety of Study Drug Therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Positive rate of prostate biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Area Under the Serum Concentration-time Curve From Zero to the Last Measurable Concentration (AUC0-t) of Dinutuximab Beta
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Serum Concentration (Cmax) of Dinutuximab Beta
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility measured by count of consumed multinutrients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Diagnosis of Autism Spectrum Disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Characterization of human dysbiosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Characterization of human metabolomics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Biomarker discovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of treatment related adverse events (TRAE)
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of severe adverse events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: all-cause and diseases-specific mortality
Endpoint domain: Mortality/survival
Primary endpoint: Change in Sleep Condition Indicator (SCI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in standardized dyspnea score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in cigarette use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fetal Cardiac Function Parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Occurrence of neoplasms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Occurrence of type 2 diabetes mellitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: MIP-1α levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recruitment potential
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participant burden
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of maternal and fetal complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with postoperative palatal fistula
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in Shoulder Pain and Disability Index (SPADI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Whole brain SUVR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regional brain SUVR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Total HEAD-US Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-Efficacy in Managing Chronic Conditions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of LA spread into the PPF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: platelets and leukocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reduction in neuropathic leg pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Long-term clinical course
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Presence of blister
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Blister volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Blister cell number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: postoperative cosmetic satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in cognitive interference
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in divided attention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in visuospatial short term memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in subjective executive function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Post Operative Visual Acuity Impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Field Defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who successfully breastfeed their newborn baby
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adverse effects - sedation
Endpoint domain: Adverse events/effects
Primary endpoint: needle related pain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: normal mouth opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EPA and DHA levels in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Standardized heat sensitivity testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measure of reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of activated protein C resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Activity of daily living (ADL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Center for Epidemiological Studies Depression Scale (CESD-10)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Family Meaning of Nursing-Home Visits scale
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Participant's understanding of the disorder
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Impact of IMR treatment on everyday life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Importance of meeting peers in similar situations
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in parental acceptance of the gender-diverse child
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in perceived interpersonal support
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Structured Clinical Interview for DSM Disorders (SCID) Alcohol Use Disorder Module
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Form 90 Timeline Followback (TLFB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dialyzer fiber patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroconversion at month 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion at month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion at month 18
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Breakup distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Agility tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy motor tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of drug overdoses
Endpoint domain: Adverse events/effects
Primary endpoint: Exposure-adjusted incidence rate of PsA
Endpoint domain: Adverse events/effects
Primary endpoint: Change in average active workday hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in average workday MVPA minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in aerobic fitness: predicted VO2max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived effect of family participation in hospital care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NEC rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change from baseline in the score of fatigue interference
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change from baseline in the score of caregiver burden
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Risk of post operative urinary tract infections (UTI)
Endpoint domain: Adverse events/effects
Primary endpoint: PK similarity of AVT80 with Entyvio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in areas of Candida antigen skin test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Difference in redness of Candida antigen skin test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric Mean Value of Antibodies at Day 29 (HAI Assay for Influenza)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric Mean Value of Antibodies at Day 29 (PsVNA for SARS-CoV-2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in spontaneous bowel movement frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Difference in number of weeks between treatments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Best response or minimal response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who overdose
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants who achieve self-identified goals
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Number of participants who engage in substance use disorder treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of skeletal related events (SRE)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in pain response at index lesion(s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health-related quality-of-life (EORTC QLQ C30)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Health-related quality-of-life (BM22)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in functional outcomes (30s sit to stand)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Modified Borg Scale (MBS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Functional Assessment of Chronic Illness Therapy- Palliative Care (FACIT - Pal)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Strength 1RM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean systolic blood pressure (BP) (mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rise in platelet counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Return of hematocrit levels towards baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Endometrial findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Volume changes of core radiation targets and irradiated normal tissues after induction treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immune checkpoints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Environmental pollutants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: G-quadruplex levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Preferences for treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: soft tissue alteration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: volumetric alteration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Refractive error per eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in refractive error between both eyes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUROC curve of the BDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of the new blood vessels number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Changes of local blood perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Successful removal of nasogastric tube
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of reverse trigger
Endpoint domain: Adverse events/effects
Primary endpoint: Change in bacteria in the gut
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Deceptive Box Task score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Look-prediction/say-prediction test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Empathy Quotient score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ekman 60 test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frontal Behavioral Inventory score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: repair site leakage
Endpoint domain: Adverse events/effects
Primary endpoint: intra-abdominal abscess
Endpoint domain: Adverse events/effects
Primary endpoint: postoperative ileus
Endpoint domain: Adverse events/effects
Primary endpoint: Urethral Perfusion Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate for low/intermediate risk AML
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of the combination of Vyxeos plus Mylotarg
Endpoint domain: Adverse events/effects
Primary endpoint: Progression-free survival rate (PFS Rate)
Endpoint domain: Mortality/survival
Primary endpoint: Culture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: percentage of arrhythmia recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: BAT SUVmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Western Ontario and McMaster Osteoarthritis Index pain change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BPI pain change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TUG pain intensity change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antibody positivity rate of sIPV vaccine after primary immunization in infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antibody positivity rate of sIPV after booster immunization with sIPV vaccine in young children
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seropositive rate of antibodies against different enteroviruses in infants and young children
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of blood units needed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of participants with clinically important findings in vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with clinically important findings in electrocardiogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with clinically important findings in echocardiogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with clinically important findings in haematology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Participants with solicited local and systemic adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with unsolicited adverse events after each dose
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with changes in clinical laboratory tests from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with changes in vital signs from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neutrophil extracellular traps (NETs) excretion in 24h urine collection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Neutrophil extracellular traps (NETs) excretion in fasting urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Neutrophil extracellular traps (NETs) excretion in 2e morning urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Macrophages extracellular traps (MET's) excretion in 24h urine collection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Macrophages extracellular traps (MET's) excretion in fasting urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Cervical Range of Motion in extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Focus On Therapeutic Outcome (FOTO) Patient Outcome Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Lower Trapezius scapular muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: number of patients with classic ALS
Endpoint domain: Mortality/survival
Primary endpoint: number of patients with bulbar ALS
Endpoint domain: Mortality/survival
Primary endpoint: number of patients with LMN phenotypes
Endpoint domain: Mortality/survival
Primary endpoint: number of patients with UMN phenotypes
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Participants who Experienced Myelosuppression
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants who Experienced Peripheral Neuropathy
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants who Experienced Lung Disorder
Endpoint domain: Adverse events/effects
Primary endpoint: Health system costs per successful bone graft
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Nephrotoxicity in Subjects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Covert Hepatic Encephalopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of participants with pneumococcal carriage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: PROMIS parent-proxy score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PROMIS patient score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Achievement rate of healthy body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in fat percent
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in diet quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Enacted Stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Severity of gastritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of composite endpoint of no death, no surgical mitral valve-related procedures, and no moderate-severe or severe MR
Endpoint domain: Mortality/survival
Primary endpoint: Insulin secretion capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Small bowel contractility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Maximum Observed Serum Concentration (Cmax) of Olpasiran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve from Time Zero to the Last Quantifiable Concentration (AUClast) of Olpasiran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve from Time Zero to Infinity (AUCinf) of Olpasiran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dialysis Clearance of Drug From Plasma (CLD) of Olpasiran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial 2-hour Plasma Glucose (PPG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes